Carboxymethyl Cellulose

Carboxymethyl cellulose (CMC), identified by CAS number 9000-11-7, is a chemically modified form of cellulose derived from wood pulp or cotton. The modification involves adding carboxymethyl groups to cellulose molecules, creating a water-soluble polymer. CMC exists as sodium carboxymethyl cellulose (sodium CMC) or other salt forms in food applications. It is a non-caloric ingredient that does not dissolve in the stomach and passes through the digestive system largely unchanged.

CMC serves multiple functional roles in food manufacturing. As a thickener and stabilizer, it increases viscosity in products ranging from ice cream and yogurt to sauces and salad dressings. In beverages, CMC prevents sedimentation and maintains uniform texture. The ingredient functions as an emulsifier, helping oil and water-based components remain mixed. CMC also acts as a humectant, retaining moisture in baked goods and dried products, and as an anticaking agent in powdered formulations. Food manufacturers utilize CMC because it is odorless, colorless, and does not significantly alter taste profiles.

CMC has an extensive history of safety evaluation. The FDA has received zero adverse event reports associated with CMC use in foods. Additionally, no FDA recalls have involved CMC as a causative factor. The ingredient is approved for use in the European Union, where EFSA (European Food Safety Authority) has established acceptable daily intake levels. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has also reviewed CMC safety data.

Studies indicate CMC is poorly absorbed in the human gastrointestinal tract. Most consumed CMC passes through the digestive system without modification or absorption. The low molecular weight sodium salts used in food are considered safer than higher molecular weight forms. Acute toxicity studies show CMC has very low toxicity when ingested. Chronic feeding studies in animals have not identified concerning effects at levels relevant to food use.

Potential concerns center on purity and manufacturing specifications. CMC quality varies depending on production methods and degree of substitution. Impurities from manufacturing processes could theoretically pose risks, but food-grade CMC is subject to strict specifications. Some individuals report sensitivity to CMC, though immunoglobulin E-mediated allergic reactions are rare and not well-documented in scientific literature.

CMC does not hold FDA GRAS (Generally Recognized as Safe) status, meaning it was approved through the FDA's food additive petition process rather than through GRAS notification. Despite lacking GRAS designation, CMC is approved for use in the United States as a food additive with established limitations on maximum use levels in specific food categories. The FDA maintains regulations specifying permitted uses and maximum concentration levels. In the European Union, CMC is listed as food additive E466 and is permitted in numerous food categories with specified maximum levels. Many countries, including Canada and Australia, also authorize CMC use in foods with established safety parameters.

Research supporting CMC safety includes animal toxicity studies submitted to regulatory agencies and published peer-reviewed literature. A notable study published in *Food and Chemical Toxicology* examined chronic effects of CMC in laboratory animals and found no significant toxicological effects at levels substantially exceeding typical dietary exposure. Studies on intestinal permeability suggest CMC does not compromise gut barrier function at food-relevant doses. Research on CMC's metabolic fate confirms minimal absorption and rapid elimination. Additionally, the lack of genotoxic or mutagenic effects has been established in standard toxicological testing protocols required for food additive approval.